What is not working for the company?
What is working for the company?
|Name||Sep 22||Jun 22|
|Mutual Funds (Change:0.00)||0%||0%|
|Insurance Companies (Change:0.00)||0%||0%|
|Other DIIs (Change:0.00)||0%||0%|
|Non Institution (Change:0.00)||55.28%||55.28%|
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in LINCOLN PHARMA LTD
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
Frequently Asked Questions
What is the Share price of LINCOLN PHARMA LTD (LINCOLN)?
Can I buy LINCOLN PHARMA LTD (LINCOLN) shares?
How do I buy LINCOLN PHARMA LTD (LINCOLN) from Angel One?
- Direct investment: You can buy LINCOLN PHARMA LTD (LINCOLN) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to LINCOLN PHARMA LTD (LINCOLN) shares.
In which sector do LINCOLN PHARMA LTD (LINCOLN) belong?
Today's live share price for LINCOLN PHARMA LTD is NSE: ₹ 310.70, BSE: ₹ 311.00 with a current market capitalization of .
Lincoln Pharmaceuticals, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a partnership firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a public limited company in Jan. '95. All the assets and business of the erstwhile partnership was transferred to the company. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project. In 2000-01 the company has been granted ISO 9002 certificate and WHO registration.Read more